This report contains market size and forecasts of Chlamydia Infection Diagnostics in Global, including the following market information:
Global Chlamydia Infection Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chlamydia Infection Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Nucleic Acid Amplification Tests (NAATs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chlamydia Infection Diagnostics include BD Medical, Bio Rad Laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher Corporation, BioMerieux, DiaSorin SpA and Siemens AG and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chlamydia Infection Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chlamydia Infection Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chlamydia Infection Diagnostics Market Segment Percentages, by Type, 2021 (%)
Nucleic Acid Amplification Tests (NAATs)
Direct Fluorescent Tests
Others
Global Chlamydia Infection Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chlamydia Infection Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Diagnostic Centers
Global Chlamydia Infection Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chlamydia Infection Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chlamydia Infection Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chlamydia Infection Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD Medical
Bio Rad Laboratories
Novartis AG
F Hoffmann-La Roche
Abbott Laboratories
Danaher Corporation
BioMerieux
DiaSorin SpA
Siemens AG
Thermo Fisher Scientific